+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Autism Spectrum Disorder (ASD) Epidemiology Forecast 2025-2034

  • PDF Icon

    Report

  • 150 Pages
  • June 2025
  • Region: Global
  • Expert Market Research
  • ID: 6102607
Approximately 1 in 36 children are affected by autism spectrum disorder, according to the CDC's Autism and Developmental Disabilities Monitoring (ADDM) Network. Autism is reported to occur 4 times more commonly in boys than in girls and is found in all racial, ethnic, and socioeconomic groups.

Autism Spectrum Disorder (ASD) Epidemiology Forecast Report Coverage

The “Autism Spectrum Disorder (ASD) Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of autism spectrum disorder (ASD). It projects the future incidence and prevalence rates of autism spectrum disorder (ASD) across various populations. The study covers age, gender, and type as major determinants of the autism spectrum disorder (ASD)-affected population. The report highlights patterns in the prevalence of autism spectrum disorder (ASD) over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of autism spectrum disorder (ASD) in the 8 major markets.

Regions Covered

  • The United States
  • Germany
  • France
  • Italy
  • Spain
  • The United Kingdom
  • Japan
  • India

Autism Spectrum Disorder (ASD) Disease Overview

Autism spectrum disorder or autism refers to a neurological and developmental disorder that is characterized by persistent deficits in social interaction and social communication across multiple contexts. It affects how an individual interacts with others, behaves, learns, and communicates. Symptoms of autism typically appear in the first two years of life. In some cases, autistic people can live independently. However, certain patients have severe disabilities and need life-long support and care.

Autism Spectrum Disorder (ASD) Treatment Overview

Therapy, medication, and educational interventions are common treatment options for autism spectrum disorder. Speech and language therapy and occupational therapy are recommended for autistic patients to improve their communication abilities and skills for daily living, respectively. Physical therapy can help patients enhance their physical skills like balance and fine motor balance. Additionally, drugs like antipsychotics are used to address aggression, emotional distress, hyperactivity, and self-injury.

Epidemiology

The autism spectrum disorder (ASD) epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for autism spectrum disorder (ASD) by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for autism spectrum disorder (ASD) and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.
  • As per the estimates from the CDC's Autism and Developmental Disabilities Monitoring (ADDM) Network, around 1 in 26 children has been diagnosed with autism spectrum disorder.
  • According to a systematic review (2022), nearly 1 in 100 children across the globe have autism spectrum disorder.
  • The American Psychiatric Association states that diagnosis of autism is 4 times more common in males than in females.
  • As per the National Survey of Children’s Health (NSCH) (2016-2019), in the United States, the average age of autism spectrum disorder diagnosis and first intervention is 5 years and 4.7 years, respectively.

Country-wise Autism Spectrum Disorder (ASD) Epidemiology

The Autism Spectrum Disorder (ASD) epidemiology data and findings for the United States, EU-4 (Germany, Spain, Italy, France), the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of autism spectrum disorder (ASD) varies between countries owing to differences in genetic predispositions, cultural perceptions of developmental disorders and social stigma, diagnostic criteria, healthcare infrastructure, and public awareness, among others. In the United States, 1 in 36 children and 1 in 45 adults have autism, according to the Centers for Disease Control and Prevention (2023).

Scope of the Report

  • The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of autism spectrum disorder (ASD) based on several factors.
  • Autism Spectrum Disorder (ASD) Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
  • The report helps to identify the patient population and the unmet needs of autism spectrum disorder (ASD) are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

  • What are the key findings of autism spectrum disorder (ASD) epidemiology in the 8 major markets?
  • What will be the total number of patients with autism spectrum disorder (ASD) across the 8 major markets during the forecast period?
  • What was the country-wise prevalence of autism spectrum disorder (ASD) in the 8 major markets in the historical period?
  • Which country will have the highest number of autism spectrum disorder (ASD) patients during the forecast period of 2025-2034?
  • Which key factors would influence the shift in the patient population of autism spectrum disorder (ASD) during the forecast period of 2025-2034?
  • What are the currently available treatments for Autism Spectrum Disorder (ASD)?
  • What are the disease risks, signs, symptoms, and unmet needs of autism spectrum disorder (ASD)?

This product will be delivered within 3-5 business days.

Table of Contents

1 Preface
1.1 Introduction
1.2 Objectives of the Study
1.3 Research Methodology and Assumptions
2 Executive Summary
3 Autism Spectrum Disorder (ASD) Market Overview - 8 MM
3.1 Autism Spectrum Disorder (ASD) Market Historical Value (2018-2024)
3.2 Autism Spectrum Disorder (ASD) Market Forecast Value (2025-2034)
4 Autism Spectrum Disorder (ASD) Epidemiology Overview - 8 MM
4.1 Autism Spectrum Disorder (ASD) Epidemiology Scenario (2018-2024)
4.2 Autism Spectrum Disorder (ASD) Epidemiology Forecast (2025-2034)
5 Disease Overview
5.1 Signs and Symptoms
5.2 Causes
5.3 Risk Factors
5.4 Guidelines and Stages
5.5 Pathophysiology
5.6 Screening and Diagnosis
5.7 Types of Autism Spectrum Disorder (ASD)
6 Patient Profile
6.1 Patient Profile Overview
6.2 Patient Psychology and Emotional Impact Factors
7 Epidemiology Scenario and Forecast - 8 MM (218-2034)
7.1 Key Findings
7.2 Assumptions and Rationale
7.3 Diagnosed Prevalent Cases of Autism Spectrum Disorder (ASD)
7.4 Type-Specific Cases of Autism Spectrum Disorder (ASD)
7.5 Gender-Specific Cases of Autism Spectrum Disorder (ASD)
7.6 Age-Specific Cases of Autism Spectrum Disorder (ASD)
8 Epidemiology Scenario and Forecast: United States (218-2034)
8.1 Assumptions and Rationale in the United States
8.2 Diagnosed Prevalent Cases of Autism Spectrum Disorder (ASD) in the United States
8.3 Type-Specific Cases of Autism Spectrum Disorder (ASD) in the United States
8.4 Gender-Specific Cases of Autism Spectrum Disorder (ASD) in the United States
8.5 Age-Specific Cases of Autism Spectrum Disorder (ASD) in the United States
9 Epidemiology Scenario and Forecast: United Kingdom (218-2034)
9.1 Assumptions and Rationale in the United Kingdom
9.2 Diagnosed Prevalent Cases of Autism Spectrum Disorder (ASD) in the United Kingdom
9.3 Type-Specific Cases of Autism Spectrum Disorder (ASD) in the United Kingdom
9.4 Gender-Specific Cases of Autism Spectrum Disorder (ASD) in the United Kingdom
9.5 Age-Specific Cases of Autism Spectrum Disorder (ASD) in the United Kingdom
10 Epidemiology Scenario and Forecast: Germany (218-2034)
10.1 Assumptions and Rationale in Germany
10.2 Diagnosed Prevalent Cases of Autism Spectrum Disorder (ASD) in Germany
10.3 Type-Specific Cases of Autism Spectrum Disorder (ASD) in Germany
10.4 Gender-Specific Cases of Autism Spectrum Disorder (ASD) in Germany
10.5 Age-Specific Cases of Autism Spectrum Disorder (ASD) in Germany
11 Epidemiology Scenario and Forecast: France (218-2034)
11.1 Assumptions and Rationale in France
11.2 Diagnosed Prevalent Cases of Autism Spectrum Disorder (ASD) in France
11.3 Type-Specific Cases of Autism Spectrum Disorder (ASD) in France
11.4 Gender-Specific Cases of Autism Spectrum Disorder (ASD) in France
11.5 Age-Specific Cases of Autism Spectrum Disorder (ASD) in France
12 Epidemiology Scenario and Forecast: Italy (218-2034)
12.1 Assumptions and Rationale in Italy
12.2 Diagnosed Prevalent Cases of Autism Spectrum Disorder (ASD) in Italy
12.3 Type-Specific Cases of Autism Spectrum Disorder (ASD) in Italy
12.4 Gender-Specific Cases of Autism Spectrum Disorder (ASD) in Italy
12.5 Age-Specific Cases of Autism Spectrum Disorder (ASD) in Italy
13 Epidemiology Scenario and Forecast: Spain (218-2034)
13.1 Assumptions and Rationale in Spain
13.2 Diagnosed Prevalent Cases of Autism Spectrum Disorder (ASD) in Spain
13.3 Type-Specific Cases of Autism Spectrum Disorder (ASD) in Spain
13.4 Gender-Specific Cases of Autism Spectrum Disorder (ASD) in Spain
13.5 Age-Specific Cases of Autism Spectrum Disorder (ASD) in Spain
14 Epidemiology Scenario and Forecast: Japan (218-2034)
14.1 Assumptions and Rationale in Japan
14.2 Diagnosed Prevalent Cases of Autism Spectrum Disorder (ASD) in Japan
14.3 Type-Specific Cases of Autism Spectrum Disorder (ASD) in Japan
14.4 Gender-Specific Cases of Autism Spectrum Disorder (ASD) in Japan
14.5 Age-Specific Cases of Autism Spectrum Disorder (ASD) in Japan
15 Epidemiology Scenario and Forecast: India (218-2034)
15.1 Assumptions and Rationale in India
15.2 Diagnosed Prevalent Cases of Autism Spectrum Disorder (ASD) in India
15.3 Type-Specific Cases of Autism Spectrum Disorder (ASD) in India
15.4 Gender-Specific Cases of Autism Spectrum Disorder (ASD) in India
15.5 Age-Specific Cases of Autism Spectrum Disorder (ASD) in India
16 Patient Journey17 Treatment Challenges and Unmet Needs18 Key Opinion Leaders (KOL) Insights